Transcriptomics

Dataset Information

0

Gene expression changes in tumor following ADH-503 treatment


ABSTRACT: To understand the effect of ADH-503, we have employed microarray expression profiling to identify genes that change at different times 48hrs and 10 days after treatment initiation. CD11b/18 (alphaMbeta2), an integrin molecule is highly expressed on all myeloid cells and plays an important role in transendothelial migration and functional changes in these cells. Here we demonstrate that a small molecule agonist of CD11b, ADH-503 was associated reprograming tumor immunity by promoting anti-tumor immune cell populations by enhancing antigen presentation by macrophages and cDCs and together these changes resulted in stabilization of tumor growth and improvement in overall survival.

ORGANISM(S): Mus musculus

PROVIDER: GSE127258 | GEO | 2019/02/28

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA524652 | ENA
| PRJNA330468 | ENA
| PRJNA188278 | ENA
| PRJNA515786 | ENA
2021-06-25 | GSE156527 | GEO
2020-08-25 | GSE156763 | GEO
2022-08-25 | GSE211749 | GEO
2017-10-12 | GSE104820 | GEO
2016-09-30 | GSE80809 | GEO
2015-02-04 | E-GEOD-64364 | biostudies-arrayexpress